Chemical crosslinking of the subunits of HIV-1 reverse transcriptase.

Por Debyser, Z., De Clercq, E.
Publicado em 1996

Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides

Por Selvam, P., Murugesh, N., Chandramohan, M., Debyser, Z., Witvrouw, M.
Publicado em 2008

LEDGF/p75 is critical but not essential for multiple-round HIV 1 replication

Por Schrijvers, RLG, De Rijck, J, Gijsbers, R, Ronen, K, Bushman, FD, Debyser, Z
Publicado em 2010

Activity of recombinant HIV-1 integrase on mini-HIV DNA.

Por Cherepanov, P, Surratt, D, Toelen, J, Pluymers, W, Griffith, J, De Clercq, E, Debyser, Z
Publicado em 1999

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.

Por Debyser, Z, Pauwels, R, Andries, K, Desmyter, J, Kukla, M, Janssen, P A, De Clercq, E
Publicado em 1991

Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.

Por Thormar, H, Balzarini, J, Holy, A, Jindrich, J, Rosenberg, I, Debyser, Z, Desmyter, J, De Clercq, E
Publicado em 1993

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

Por De Clercq, E, Yamamoto, N, Pauwels, R, Baba, M, Schols, D, Nakashima, H, Balzarini, J, Debyser, Z, Murrer, B A, Schwartz, D
Publicado em 1992

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.

Por De Clercq, E, Yamamoto, N, Pauwels, R, Balzarini, J, Witvrouw, M, De Vreese, K, Debyser, Z, Rosenwirth, B, Peichl, P, Datema, R
Publicado em 1994

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Por Pauwels, R, Andries, K, Debyser, Z, Van Daele, P, Schols, D, Stoffels, P, De Vreese, K, Woestenborghs, R, Vandamme, A M, Janssen, C G
Publicado em 1993

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic wi...

Por Pauwels, R, Andries, K, Debyser, Z, Kukla, M J, Schols, D, Breslin, H J, Woestenborghs, R, Desmyter, J, Janssen, M A, De Clercq, E
Publicado em 1994

The fetal patient – ethical aspects of fetal therapy

Por Deprest, J., Toelen, J., Debyser, Z., Rodrigues, C., Devlieger, R., De Catte, L., Lewi, L., Van Mieghem, T., Naulaers, G., Vandevelde, M., Claus, F., Dierickx, K.
Publicado em 2011

The fetal respiratory system as target for antenatal therapy

Por Toelen, J., Carlon, M., Claus, F., Gijsbers, R., Sandaite, I., Dierickx, K., Devlieger, R., Devriendt, K., Debeer, A., Proesmans, M., Debyser, Z., Deprest, A.J.
Publicado em 2011

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.

Por Witvrouw, M, Balzarini, J, Pannecouque, C, Jhaumeer-Laulloo, S, Esté, J A, Schols, D, Cherepanov, P, Schmit, J C, Debyser, Z, Vandamme, A M, Desmyter, J, Ramadas, S R, de Clercq, E
Publicado em 1997